CRISPR-Cas Antimicrobial Platforms for Multidrug-Resistant Infections: From Molecular Mechanisms to Therapeutic Applications
International Journal of Drug Delivery Technology · 21.05.2026 · 16 (42s)
DOI: 10.25258/ijddt.16.42s.136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 21.05.2026. Verfasst von Hareem Fatima Niazi und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Carbapenem-resistant Klebsiella pneumoniae harboring KPC variants represents a critical antimicrobial resistance threat. This study evaluated CRISPR-Cas antimicrobial platforms targeting bla KPC-2 / bla KPC-3 in twelve clinical MDR isolates. Using CLSI-standardized broth microdilution and phage-delivered CRISPR constructs, we assessed plasmid curing, MIC reversion, and off-target effects. Treatment achieved targeted plasmid elimination in 91.7% of isolates, restoring carbapenem susceptibility (≥8-fold MIC reduction) without genomic damage to KPC-negative controls or commensal flora. CRISPR-Cas platforms enable precise, sequence-specific reversal of KPC-mediated resistance, supporting their therapeutic potential pending delivery optimization and ecological surveillance.
Zitieren
APA
Niazi, H. F., Ismail, T., Fida, M., Iqbal, A., Hakim, Z., Rehman, A., Ghaib, A. U., & Bibi, R. (2026). CRISPR-Cas Antimicrobial Platforms for Multidrug-Resistant Infections: From Molecular Mechanisms to Therapeutic Applications. International Journal of Drug Delivery Technology, 16(42s). https://doi.org/10.25258/ijddt.16.42s.136
Vancouver
Niazi HF, Ismail T, Fida M, Iqbal A, Hakim Z, Rehman A, et al. CRISPR-Cas Antimicrobial Platforms for Multidrug-Resistant Infections: From Molecular Mechanisms to Therapeutic Applications. International Journal of Drug Delivery Technology. 2026;16(42s). doi:10.25258/ijddt.16.42s.136
BibTeX
@article{Niazi2026,
author = {Niazi, Hareem Fatima and Ismail, Tahseen and Fida, Muqaddas and Iqbal, Asma and Hakim, Zunera and Rehman, Ayesha and Ghaib, Asad Ullah and Bibi, Rashida},
title = {CRISPR-Cas Antimicrobial Platforms for Multidrug-Resistant Infections: From Molecular Mechanisms to Therapeutic Applications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {42s},
doi = {10.25258/ijddt.16.42s.136}
}
EUVIMED